LITIGATION MANAGEMENT AGREEMENTLitigation Management Agreement • February 13th, 2017 • Pershing Square Capital Management, L.P. • Pharmaceutical preparations • New York
This Litigation Management Agreement (the “Agreement”) is entered into as of February 10, 2017, by and among (1) Valeant Pharmaceuticals International, Inc. and Valeant Pharmaceuticals International (together, “Valeant”); (2) J. Michael Pearson (“Pearson” and, together with Valeant, the “Valeant Parties”); and (3) Pershing Square Capital Management, L.P., Pershing Square Holdings, Ltd., Pershing Square International, Ltd., Pershing Square, L.P., Pershing Square II, L.P., PS Management GP, LLC, PS Fund 1, LLC, Pershing Square GP, LLC (together, “Pershing Square”), and William A. Ackman (“Ackman” and, together with Pershing Square, the “Pershing Square Parties”). For purposes of this Agreement, the “Parties” shall mean the Valeant Parties and the Pershing Square Parties.
